ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1794

Venous Vessel Wall Thickness in Lower Extremity Is Increased in Male Behcet’s Disease Patients

Fatma Alibaz-Oner1, Rabia Ergelen2, Aydan Mutiş3, Zeynep Erturk1, Ruslan Asadov4, Tulin Ergun5 and Haner Direskeneli6, 1Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, 2Marmara University School of Medicine, Radiology, ISTANBUL, Turkey, 3Marmara University, School of Medicine, Rheumatology, ISTANBUL, Turkey, 4Marmara University School of Medicine, Radiology, Istanbul, Turkey, 5Marmara University, School of Medicine, Dermatology, Istanbul, Turkey, 6Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Vascular involvement is seen in up to 40% of the patients with Behcet’s Disease (BD), especially in young males and is one of the major causes of mortality and morbidity. Lower extremity vein thrombosis due to vascular inflammation is the most frequent form of vascular involvement in BD. Recently, assessment of vessel wall thickness (VWT) and venous dilatation by US is suggested to be valuable in patients with vascular inflammation. In this study, we investigated whether vessel wall thickness or dilatation is present in young male BD patients prone to venous vascular disease.

Methods: Thirty male patients with BD without major organ involvement and 29 male patients with Vascular BD (VBD) followed in Marmara University Behcet’s Clinics, 24 healthy male controls and 27 male patients with ankylosing spondylitis (AS) were included the study. Bilateral lower extremity venous doppler ultrasonography (US) was performed by an experienced radiologist blinded to cases. No patients except VBD were under immunosuppressive treatment. Bilateral common femoral vein (CFV) wall thickness and great/small saphenous vein dilatations were examined. Behçet Syndrome Activity Score (BSAS) was used for the general assessment of disease activity. In 10 patients, CFV wall thickness was measured by 2 different radiologist (RE, RA) in the same day to calculate “inter-observer reliability”. Correlation between radiologists was good (r= 0.765, p<0.001).

Results: Mean disease duration was 9.1±6 years in patients with BD. BSAS score was 24±17. All venous measurements were significantly higher in BD compared to AS and healthy controls (p<0.001 for all, Table 1). When we compared mucocutaneous BD (m-BD) vs VBD, all measurements of patients with VBD were higher than m-BD, however only left CFV thickness and width of right great saphenous vein reached statistical significance (p<0.001, and p=0.028, respectively). There were no correlations between BSAS, acute phase reactants and venous wall measurements.

.

Table 1: Venous wall measurements of lower extremity in study groups.

Behçet’s Disease (n=59)

Ankylosing Spondylitis (n=27)

Healthy Controls (n=28)

P Value

Age, years

32.5 (23-42)

32 (20-37)

31.5 (25-42)

0.23

Body Mass Index (kg/m2)

25.1 (18-33)

25 (18-32)

23.8 (20-29)

0.213

Right Common femoral VWT (mm)

0.8 (0.04-1.8)

0.3 (0.1-0.6)

0.25 (0.06-0.4)

<0.001

Left Common femoral VWT (mm)

0.8 (0.3-1.6)

0.3 (0.1-0.5)

0.2 (0.04-0.6)

<0.001

Right Great saphenous width (mm)

3.1 (0-6.4)

2.5 (1.1-3.5)

2.1 (1.3-3.5)

<0.001

Left Great saphenous width (mm)

3.1 (0-7.4)

2.6 (0.3-4.8)

2.4 (1.6-3.6)

<0.001

Right Small saphenous width (mm)

2.8 (0-5.3)

1.7 (1-3.1)

1.4 (0.9-3.7)

<0.001

Left Small saphenous width (mm)

2.7 (0-5.2)

1.8 (1.1-3.4)

1.6 (0.8-3.6)

<0.001

VWT: Venous wall thickness

Conclusion: In our study, an increased venous vessel wall thickness in lower extremity was shown in male BD patients with or without vascular involvement. As a similar change was not observed in control groups, increased VWT might be an early sign of venous inflammation in patients with BD rather than a result of non-specific systemic inflammation.


Disclosure: F. Alibaz-Oner, None; R. Ergelen, None; A. Mutiş, None; Z. Erturk, None; R. Asadov, None; T. Ergun, None; H. Direskeneli, None.

To cite this abstract in AMA style:

Alibaz-Oner F, Ergelen R, Mutiş A, Erturk Z, Asadov R, Ergun T, Direskeneli H. Venous Vessel Wall Thickness in Lower Extremity Is Increased in Male Behcet’s Disease Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/venous-vessel-wall-thickness-in-lower-extremity-is-increased-in-male-behcets-disease-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/venous-vessel-wall-thickness-in-lower-extremity-is-increased-in-male-behcets-disease-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology